JPMorgan Chase & Co’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$108K Buy
2025
Q1
$133K Sell
2024
Q4
$613K Buy
2024
Q3
$173K Buy
2024
Q2
$151K Buy
2024
Q1
$119K Sell
2023
Q4
$214K Sell
2023
Q3
$230K Sell
2023
Q2
$252K Buy
2023
Q1
$124K Buy
2022
Q4
$103K Buy
2022
Q2
Sell
2022
Q1
$46K Buy
2021
Q4
$60K Buy